Botanix Pharmaceuticals
BOT.AX
#6992
Rank
ยฃ0.31 B
Marketcap
ยฃ0.17
Share price
-1.47%
Change (1 day)
132.25%
Change (1 year)

P/E ratio for Botanix Pharmaceuticals (BOT.AX)

P/E ratio at the end of 2023: -13.2

According to Botanix Pharmaceuticals's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -42.2325. At the end of 2023 the company had a P/E ratio of -13.2.

P/E ratio history for Botanix Pharmaceuticals from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2023-13.2233.03%
2022-3.98-80.99%
2021-20.9926.37%
2020-2.04-73.73%
2019-7.7678.89%
2018-4.3429.26%
2017-3.3570.98%
2016-1.96-10.98%
2015-2.2050.72%
2014-1.46487.67%
2013-0.2488-36.24%
2012-0.3903-31.76%
2011-0.5719-62.07%
2010-1.51-67.29%
2009-4.61-3.06%
2008-4.75-0.91%
2007-4.802.56%
2006-4.681084.23%
2005-0.3951-85.54%
2004-2.73131.4%
2003-1.18-25.66%
2002-1.59-89.37%
2001-14.9

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.